The weight-loss drug Wegovy (semaglutide), manufactured by the Danish company Novo Nordisk, received approval on 20 March and the company confirms it is exploring options to make the drug available locally as soon as possible, but has no time frame for this.
Medsafe approval for the weight-loss medication Wegovy adds an effective tool to the obesity treatment toolbox, says Auckland endocrinologist and Diabetes Foundation Aotearoa chair John Baker
Dietitian Sarah MacAvoy discusses the symptoms of Parkinson disease that affect a person’s ability to maintain good nutrition and those that can be improved with dietary strategies. She also looks at how food and medications interact
Dietitian Sarah Munn discusses the risks and symptoms associated with perimenopause and menopause, and gives dietary and lifestyle recommendations to support wellbeing during this phase of life
Dietitian Joanna Paggi discusses nutritional considerations during early pregnancy, including food safety, weight gain recommendations, nausea and vomiting, and supplements
Lactose intolerance is a common digestive issue affecting a significant proportion of the population. Dunedin pharmacist Darshana Kanjee looks at what pharmacy staff can do to help
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes